Private equity sponsors can exhale: A federal court recently stopped the Federal Trade Commission’s (FTC) antitrust action that targeted private equity sponsor Welsh, Carson, Anderson & Stowe for the healthcare “roll-up” strategy of its anesthesia practice management portfolio company. The case, Federal Trade Commission v. U.S. Anesthesia Partners, Inc. et al., might prove to be a milestone – and perhaps a turning point – in the recent trend of federal and state scrutiny of private equity sponsor investment in the healthcare industry.
Read the full article: Recent Ruling Shows Healthcare Private Equity Firms a Path through the New Antitrust Era //
Source: https://www.hklaw.com/en/insights/publications/2024/06/recent-ruling-shows-healthcare-private-equity-firms-a-path-through